223.2K XNYS Volume
XNYS 20 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Barbara A. Jacobsmeyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 133,541 | 578,711 | - | 8.0 | 1,070,999 | Common Stock |
| Barbara A. Jacobsmeyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 27,822 | 456,003 | - | 8.0 | 223,132 | Common Stock |
| Barbara A. Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 06 Mar 2025 | 10,833 | 445,170 | - | 8.0 | 86,881 | Common Stock |
| Collin McQuiddy | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 06 Mar 2025 | 463 | 1,096 | - | 8.0 | 3,713 | Common Stock |
| Collin McQuiddy | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 5,986 | 5,986 | - | 8.0 | 48,008 | Common Stock |
| Collin McQuiddy | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.58 per share. | 06 Mar 2025 | 1,096 | 0 | - | 8.6 | 9,404 | Common Stock |
| Collin McQuiddy | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 1,559 | 1,559 | - | 8.0 | 12,503 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 7,638 | 44,781 | - | 8.0 | 61,257 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 06 Mar 2025 | 2,604 | 42,177 | - | 8.0 | 20,884 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 17,457 | 59,634 | - | 8.0 | 140,005 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 8,510 | 70,744 | - | 8.0 | 68,250 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 24,439 | 92,259 | - | 8.0 | 196,001 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 06 Mar 2025 | 2,924 | 67,820 | - | 8.0 | 23,450 | Common Stock |
| Dylan C Black | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 7,638 | 30,500 | - | 8.0 | 61,257 | Common Stock |
| Dylan C Black | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 19,452 | 47,177 | - | 8.0 | 156,005 | Common Stock |
| Dylan C Black | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 06 Mar 2025 | 2,775 | 27,725 | - | 8.0 | 22,256 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 06 Mar 2025 | 2,377 | 56,164 | - | 8.0 | 19,064 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 7,092 | 58,541 | - | 8.0 | 56,878 | Common Stock |
| Ryan Solomon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 31,173 | 146,099 | - | 8.0 | 250,007 | Common Stock |
| Ryan Solomon | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 06 Mar 2025 | 270 | 114,926 | - | 8.0 | 2,165 | Common Stock |
| Ryan Solomon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 06 Mar 2025 | 910 | 115,196 | - | 8.0 | 7,298 | Common Stock |
| Barbara A. Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 01 Mar 2025 | 17,997 | 428,181 | - | 8.4 | 150,635 | Common Stock |
| Jeanne L. Kalvaitis | EVP of Hospice Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 01 Mar 2025 | 1,148 | 9,881 | - | 8.4 | 9,609 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 01 Mar 2025 | 3,374 | 37,143 | - | 8.4 | 28,240 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 01 Mar 2025 | 3,821 | 62,234 | - | 8.4 | 31,982 | Common Stock |
| Dylan C Black | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 01 Mar 2025 | 2,609 | 22,862 | - | 8.4 | 21,837 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 01 Mar 2025 | 3,041 | 51,449 | - | 8.4 | 25,453 | Common Stock |
| Barbara A. Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.26 per share. | 25 Feb 2025 | 7,973 | 446,178 | - | 8.3 | 65,857 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.26 per share. | 25 Feb 2025 | 346 | 40,517 | - | 8.3 | 2,858 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.26 per share. | 25 Feb 2025 | 614 | 66,055 | - | 8.3 | 5,072 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.26 per share. | 25 Feb 2025 | 334 | 54,490 | - | 8.3 | 2,759 | Common Stock |
| Barry P. Schochet | Director | Grant, award, or other acquisition of securities at price $ 7.80 per share. | 10 Jan 2025 | 3,045 | 42,883 | - | 7.8 | 23,751 | Common Stock |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 7.80 per share. | 10 Jan 2025 | 2,404 | 54,386 | - | 7.8 | 18,751 | Common Stock |
| Gregory S. Rush | Director | Grant, award, or other acquisition of securities at price $ 7.80 per share. | 10 Jan 2025 | 3,205 | 50,593 | - | 7.8 | 24,999 | Common Stock |
| Stuart M. McGuigan | Director | Grant, award, or other acquisition of securities at price $ 7.80 per share. | 10 Jan 2025 | 2,404 | 49,214 | - | 7.8 | 18,751 | Common Stock |
| Erin P. Hoeflinger | Director | Grant, award, or other acquisition of securities at price $ 7.80 per share. | 10 Jan 2025 | 3,045 | 51,358 | - | 7.8 | 23,751 | Common Stock |
| Jeffrey W. Bolton | Director | Grant, award, or other acquisition of securities at price $ 7.80 per share. | 10 Jan 2025 | 4,808 | 102,952 | - | 7.8 | 37,502 | Common Stock |
| Mark W. Ohlendorf | Director | Grant, award, or other acquisition of securities at price $ 7.80 per share. | 10 Jan 2025 | 2,404 | 19,615 | - | 7.8 | 18,751 | Common Stock |
| Barbara A. Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 6,088 | 454,151 | - | 7.8 | 47,547 | Common Stock |
| Barbara A. Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 10,746 | 460,239 | - | 7.8 | 83,926 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 1,099 | 41,564 | - | 7.8 | 8,583 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 701 | 40,863 | - | 7.8 | 5,475 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 2,113 | 68,014 | - | 7.8 | 16,503 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 1,345 | 66,669 | - | 7.8 | 10,504 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 656 | 54,824 | - | 7.8 | 5,123 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.81 per share. | 01 Jan 2025 | 1,031 | 55,480 | - | 7.8 | 8,052 | Common Stock |
| Jeffrey Bolton W. | Director | Purchase of securities on an exchange or from another person at price $ 8.69 per share. | 12 Dec 2024 | 4,000 | 98,144 | - | 8.7 | 34,760 | Common Stock |
| Stuart M. McGuigan | Director | Purchase of securities on an exchange or from another person at price $ 8.81 per share. | 10 Dec 2024 | 15,000 | 46,810 | - | 8.8 | 132,150 | Common Stock |
| Jeffrey W. Bolton | Director | Purchase of securities on an exchange or from another person at price $ 7.75 per share. | 08 Nov 2024 | 649 | 84,793 | - | 7.8 | 5,030 | Common Stock |
| Jeffrey W. Bolton | Director | Purchase of securities on an exchange or from another person at price $ 7.60 per share. | 08 Nov 2024 | 3,000 | 94,144 | - | 7.6 | 22,800 | Common Stock |
| Jeffrey W. Bolton | Director | Purchase of securities on an exchange or from another person at price $ 7.77 per share. | 08 Nov 2024 | 6,351 | 91,144 | - | 7.8 | 49,347 | Common Stock |
| Barry P. Schochet | Director | Grant, award, or other acquisition of securities at price $ 7.12 per share. | 10 Oct 2024 | 3,336 | 39,838 | - | 7.1 | 23,752 | Common Stock |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 7.12 per share. | 10 Oct 2024 | 2,633 | 51,982 | - | 7.1 | 18,747 | Common Stock |
| Gregory S. Rush | Director | Grant, award, or other acquisition of securities at price $ 7.12 per share. | 10 Oct 2024 | 3,511 | 47,388 | - | 7.1 | 24,998 | Common Stock |
| Stuart M. McGuigan | Director | Grant, award, or other acquisition of securities at price $ 7.12 per share. | 10 Oct 2024 | 2,633 | 31,810 | - | 7.1 | 18,747 | Common Stock |
| Erin P. Hoeflinger | Director | Grant, award, or other acquisition of securities at price $ 7.12 per share. | 10 Oct 2024 | 3,336 | 48,313 | - | 7.1 | 23,752 | Common Stock |
| Jeffrey W. Bolton | Director | Grant, award, or other acquisition of securities at price $ 7.12 per share. | 10 Oct 2024 | 5,267 | 84,144 | - | 7.1 | 37,501 | Common Stock |
| Mark W. Ohlendorf | Director | Grant, award, or other acquisition of securities at price $ 7.12 per share. | 10 Oct 2024 | 2,633 | 17,211 | - | 7.1 | 18,747 | Common Stock |
| Jeffrey W. Bolton | Director | Purchase of securities on an exchange or from another person at price $ 8.01 per share. | 22 Aug 2024 | 5,000 | 78,877 | - | 8.0 | 40,050 | Common Stock |
| Jeffrey W. Bolton | Director | Purchase of securities on an exchange or from another person at price $ 8.29 per share. | 08 Aug 2024 | 5,000 | 73,877 | - | 8.3 | 41,450 | Common Stock |
| Jeffrey W. Bolton | Director | Purchase of securities on an exchange or from another person at price $ 8.60 per share. | 08 Aug 2024 | 2,000 | 68,877 | - | 8.6 | 17,200 | Common Stock |
| Barry P. Schochet | Director | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 25 Jul 2024 | 14,578 | 36,502 | - | 10.3 | 150,008 | Common Stock |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 25 Jul 2024 | 14,578 | 49,349 | - | 10.3 | 150,008 | Common Stock |
| Gregory S. Rush | Director | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 25 Jul 2024 | 14,578 | 43,877 | - | 10.3 | 150,008 | Common Stock |
| Stuart M. McGuigan | Director | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 25 Jul 2024 | 14,578 | 29,177 | - | 10.3 | 150,008 | Common Stock |
| Erin P. Hoeflinger | Director | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 25 Jul 2024 | 14,578 | 44,977 | - | 10.3 | 150,008 | Common Stock |
| Jeffrey W. Bolton | Director | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 25 Jul 2024 | 14,578 | 66,877 | - | 10.3 | 150,008 | Common Stock |
| Tina L. Brown-Stevenson | Director | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 25 Jul 2024 | 14,578 | 36,925 | - | 10.3 | 150,008 | Common Stock |
| Crissy B. Carlisle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.75 per share. | 01 Jul 2024 | 1,779 | 86,563 | - | 8.7 | 15,566 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.75 per share. | 01 Jul 2024 | 1,302 | 70,127 | - | 8.8 | 11,393 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.75 per share. | 01 Jul 2024 | 673 | 56,491 | - | 8.8 | 5,889 | Common Stock |
| Jeffrey W. Bolton | Director | Purchase of securities on an exchange or from another person at price $ 8.33 per share. | 17 May 2024 | 10,000 | 52,299 | - | 8.3 | 83,300 | Common Stock |
| Erin P. Hoeflinger | Director | Purchase of securities on an exchange or from another person at price $ 9.00 per share. | 14 May 2024 | 2,000 | 30,399 | - | 9 | 18,000 | Common Stock |
| Jeffrey W. Bolton | Director | Purchase of securities on an exchange or from another person at price $ 8.24 per share. | 10 May 2024 | 10,000 | 42,299 | - | 8.2 | 82,400 | Common Stock |
| Jeanne L. Kalvaitis | EVP of Hospice Operations | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 07 Mar 2024 | 4,287 | 14,168 | - | 8.0 | 34,382 | Common Stock |
| Jeanne L. Kalvaitis | EVP of Hospice Operations | Grant, award, or other acquisition of securities at price $ 8.02 per share. | 07 Mar 2024 | 10,288 | 23,184 | - | 8.0 | 82,510 | Common Stock |
| Jeanne L. Kalvaitis | EVP of Hospice Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.02 per share. | 07 Mar 2024 | 1,272 | 12,896 | - | 8.0 | 10,201 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Grant, award, or other acquisition of securities at price $ 8.81 per share. | 01 Mar 2024 | 15,027 | 57,798 | - | 8.8 | 132,388 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Sale of securities on an exchange or to another person at price $ 8.81 per share. | 01 Mar 2024 | 634 | 57,164 | - | 8.8 | 5,586 | Common Stock |
| Barbara Jacobsmeyer A. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 8.81 per share. | 01 Mar 2024 | 114,302 | 475,576 | - | 8.8 | 1,007,001 | Common Stock |
| Barbara Jacobsmeyer A. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.81 per share. | 01 Mar 2024 | 4,591 | 470,985 | - | 8.8 | 40,447 | Common Stock |
| Crissy B. Carlisle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.81 per share. | 01 Mar 2024 | 1,327 | 88,342 | - | 8.8 | 11,691 | Common Stock |
| Crissy B. Carlisle | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.81 per share. | 01 Mar 2024 | 18,144 | 89,669 | - | 8.8 | 159,849 | Common Stock |
| Jeanne L. Kalvaitis | EVP of Hospice Operations | Grant, award, or other acquisition of securities at price $ 8.81 per share. | 01 Mar 2024 | 5,764 | 11,607 | - | 8.8 | 50,781 | Common Stock |
| Jeanne L. Kalvaitis | EVP of Hospice Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.81 per share. | 01 Mar 2024 | 578 | 11,029 | - | 8.8 | 5,092 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 8.81 per share. | 01 Mar 2024 | 16,308 | 43,435 | - | 8.8 | 143,673 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.81 per share. | 01 Mar 2024 | 772 | 42,663 | - | 8.8 | 6,801 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Grant, award, or other acquisition of securities at price $ 8.81 per share. | 01 Mar 2024 | 18,144 | 72,464 | - | 8.8 | 159,849 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.81 per share. | 01 Mar 2024 | 1,035 | 71,429 | - | 8.8 | 9,118 | Common Stock |
| Dylan C Black | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 8.81 per share. | 01 Mar 2024 | 14,942 | 26,381 | - | 8.8 | 131,639 | Common Stock |
| Dylan C Black | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.81 per share. | 01 Mar 2024 | 910 | 25,471 | - | 8.8 | 8,017 | Common Stock |
| R. Marion Tanya | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 25 Feb 2024 | 346 | 27,127 | - | 9.5 | 3,284 | Common Stock |
| Carlisle B. Crissy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 205 | 72,292 | - | 9.5 | 1,945 | Common Stock |
| Crissy B. Carlisle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 767 | 71,525 | - | 9.5 | 7,279 | Common Stock |
| Jacobsmeyer Barbara A. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 5,063 | 361,274 | - | 9.5 | 48,048 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 181 | 43,104 | - | 9.5 | 1,718 | Common Stock |
| Leroy Ronald Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 333 | 42,771 | - | 9.5 | 3,160 | Common Stock |
| Julie Jolley D. | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 181 | 54,934 | - | 9.5 | 1,718 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 614 | 54,320 | - | 9.5 | 5,827 | Common Stock |
| Barbara Jacobsmeyer A. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.49 per share. | 24 Feb 2024 | 789 | 366,337 | - | 9.5 | 7,488 | Common Stock |
| P. Schochet Barry | Director | Other type of transaction at price $ 8.61 per share. | 11 Jan 2024 | 788 | 19,383 | - | 8.6 | 6,785 | Common Stock |
| P. Barry Schochet | Director | Other type of transaction at price $ 13.58 per share. | 11 Jan 2024 | 671 | 15,270 | - | 13.6 | 9,112 | Common Stock |
| P. Barry Schochet | Director | Other type of transaction at price $ 8.41 per share. | 11 Jan 2024 | 820 | 20,203 | - | 8.4 | 6,896 | Common Stock |
| Barry P. Schochet | Director | Other type of transaction at price $ 12.73 per share. | 11 Jan 2024 | 1,126 | 16,396 | - | 12.7 | 14,334 | Common Stock |
| P. Schochet Barry | Director | Other type of transaction at price $ 13.79 per share. | 11 Jan 2024 | 1,079 | 17,475 | - | 13.8 | 14,879 | Common Stock |
| Schochet Barry P. | Director | Other type of transaction at price $ 8.59 per share. | 11 Jan 2024 | 1,721 | 21,924 | - | 8.6 | 14,783 | Common Stock |
| Barry Schochet P. | Director | Other type of transaction at price $ 12.63 per share. | 11 Jan 2024 | 390 | 17,865 | - | 12.6 | 4,926 | Common Stock |
| Schochet P. Barry | Director | Other type of transaction at price $ 13.58 per share. | 11 Jan 2024 | 730 | 18,595 | - | 13.6 | 9,913 | Common Stock |
| D. Julie Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.35 per share. | 01 Jan 2024 | 1,043 | 55,115 | - | 10.3 | 10,795 | Common Stock |
| Leroy Ronald Langham | EVP Clinical Excel. & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.35 per share. | 01 Jan 2024 | 1,043 | 43,285 | - | 10.3 | 10,795 | Common Stock |
| Barbara Jacobsmeyer A. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.35 per share. | 01 Jan 2024 | 9,928 | 367,126 | - | 10.4 | 102,755 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.65 per share. | 04 Oct 2023 | 1,636 | 56,158 | - | 8.6 | 14,151 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.50 per share. | 01 Jul 2023 | 703 | 27,473 | - | 11.5 | 8,085 | Common Stock |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.50 per share. | 01 Jul 2023 | 1,044 | 57,794 | - | 11.5 | 12,006 | Common Stock |
| Barry P. Schochet | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 14,599 | - | 11.8 | 150,011 | Common Stock |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 34,771 | - | 11.8 | 150,011 | Common Stock |
| Gregory S. Rush | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 29,299 | - | 11.8 | 150,011 | Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 30,092 | - | 11.8 | 150,011 | Common Stock |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 29,776 | - | 11.8 | 150,011 | Common Stock |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 51,691 | - | 11.8 | 150,011 | Common Stock |
| Stuart M. McGuigan | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 14,599 | - | 11.8 | 150,011 | Common Stock |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 30,310 | - | 11.8 | 150,011 | Common Stock |
| Erin Hoeflinger | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 28,399 | - | 11.8 | 150,011 | Common Stock |
| Susan LaMonica | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 35,797 | - | 11.8 | 150,011 | Common Stock |
| Jeffrey Bolton | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 32,299 | - | 11.8 | 150,011 | Common Stock |
| Tina L. Brown-Stevenson | Director | Grant, award, or other acquisition of securities at price $ 11.81 per share. | 28 Jun 2023 | 12,702 | 22,347 | - | 11.8 | 150,011 | Common Stock |
| Jeffrey Bolton | Director | Purchase of securities on an exchange or from another person at price $ 11.61 per share. | 26 May 2023 | 2,000 | 19,597 | - | 11.6 | 23,220 | Common Stock |
| L. Edward Shaw | Director | Purchase of securities on an exchange or from another person at price $ 11.98 per share. | 22 May 2023 | 10,000 | 38,989 | - | 12.0 | 119,800 | Common Stock |
| Erin Hoeflinger | Director | Purchase of securities on an exchange or from another person at price $ 11.82 per share. | 18 May 2023 | 2,100 | 15,697 | - | 11.8 | 24,822 | Common Stock |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Purchase of securities on an exchange or from another person at price $ 11.99 per share. | 18 May 2023 | 10,000 | 44,328 | - | 12.0 | 119,900 | Common Stock |
| Jeffrey Bolton | Director | Purchase of securities on an exchange or from another person at price $ 11.80 per share. | 17 May 2023 | 2,000 | 17,597 | - | 11.8 | 23,600 | Common Stock |
| Barbara Jacobsmeyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 35,001 | 273,443 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 13,072 | 57,888 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,268 | 61,156 | - | 0 | Common Stock | |
| Jeanne L. Kalvaitis | EVP of Hospice Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 4,674 | 4,674 | - | 0 | Common Stock | |
| Jeanne L. Kalvaitis | EVP of Hospice Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,169 | 5,843 | - | 0 | Common Stock | |
| Tanya R. Marion | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,863 | 19,115 | - | 0 | Common Stock | |
| Tanya R. Marion | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,716 | 20,831 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,197 | 32,150 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,550 | 34,700 | - | 0 | Common Stock | |
| Dylan C Black | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 9,151 | 9,151 | - | 0 | Common Stock | |
| Dylan C Black | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,288 | 11,439 | - | 0 | Common Stock | |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,594 | 34,328 | - | 0 | Common Stock | |
| Ronald Leroy Langham | EVP Clinical Excel. & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,373 | 32,734 | - | 0 | Common Stock | |
| Tanya R. Marion | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 25 Feb 2023 | 345 | 19,597 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 735 | 347,904 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 789 | 347,115 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 1,180 | 345,935 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 3,882 | 342,053 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 2,154 | 353,031 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 4,392 | 348,639 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 205 | 56,925 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 184 | 57,130 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 270 | 57,314 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 473 | 57,584 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 767 | 56,158 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 248 | 47,054 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 169 | 46,885 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 181 | 46,704 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 613 | 46,091 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2023 | 433 | 47,302 | - | 0 | Common Stock | |
| Jeffrey Bolton | Director | Purchase of securities on an exchange or from another person at price $ 12.69 per share. | 18 Nov 2022 | 1,000 | 15,597 | - | 12.7 | 12,690 | Common Stock |
| Leo I. Higdon | Director | Purchase of securities on an exchange or from another person at price $ 13.57 per share. | 08 Nov 2022 | 426 | 7,926 | - | 13.6 | 5,781 | Common Stock |
| Jeffrey Bolton | Director | Purchase of securities on an exchange or from another person at price $ 12.75 per share. | 08 Nov 2022 | 2,000 | 14,597 | - | 12.8 | 25,500 | Common Stock |
| Jeffrey Bolton | Director | Purchase of securities on an exchange or from another person at price $ 12.89 per share. | 08 Nov 2022 | 2,000 | 12,597 | - | 12.9 | 25,780 | Common Stock |
| Gregory S. Rush | Director | Purchase of securities on an exchange or from another person at price $ 12.58 per share. | 04 Nov 2022 | 1,700 | 8,297 | - | 12.6 | 21,386 | Common Stock |
| Gregory S. Rush | Director | Purchase of securities on an exchange or from another person at price $ 12.69 per share. | 04 Nov 2022 | 8,300 | 16,597 | - | 12.7 | 105,327 | Common Stock |
| Tina L. Brown-Stevenson | Director | Purchase of securities on an exchange or from another person at price $ 15.99 per share. | 31 Aug 2022 | 1,550 | 9,645 | - | 16.0 | 24,785 | Common Stock |
| Erin Hoeflinger | Director | Purchase of securities on an exchange or from another person at price $ 13.90 per share. | 18 Aug 2022 | 970 | 13,597 | - | 13.9 | 13,483 | Common Stock |
| Erin Hoeflinger | Director | Purchase of securities on an exchange or from another person at price $ 13.62 per share. | 18 Aug 2022 | 6,030 | 12,627 | - | 13.6 | 82,129 | Common Stock |
| Tanya R. Marion | Chief Human Resources Officer | Purchase of securities on an exchange or from another person at price $ 14.60 per share. | 17 Aug 2022 | 1,712 | 1,712 | - | 14.6 | 24,995 | Common Stock |
| Charles M. Elson | Director | Purchase of securities on an exchange or from another person at price $ 13.55 per share. | 11 Aug 2022 | 3,700 | 22,069 | - | 13.6 | 50,135 | Common Stock |
| L. Edward Shaw | Director | Purchase of securities on an exchange or from another person at price $ 13.64 per share. | 09 Aug 2022 | 10,000 | 28,989 | - | 13.6 | 136,400 | Common Stock |
| Barbara Jacobsmeyer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 13.78 per share. | 09 Aug 2022 | 30,000 | 238,442 | - | 13.8 | 413,400 | Common Stock |
| John E. Maupin | Director | Purchase of securities on an exchange or from another person at price $ 13.59 per share. | 08 Aug 2022 | 1,000 | 17,390 | - | 13.6 | 13,590 | Common Stock |
| Yvonne M. Curl | Director | Purchase of securities on an exchange or from another person at price $ 13.75 per share. | 08 Aug 2022 | 1,500 | 17,608 | - | 13.8 | 20,625 | Common Stock |
| Leo I. Higdon | Director | Purchase of securities on an exchange or from another person at price $ 12.37 per share. | 04 Aug 2022 | 3,000 | 7,500 | - | 12.4 | 37,110 | Common Stock |
| Susan LaMonica | Director | Purchase of securities on an exchange or from another person at price $ 11.72 per share. | 04 Aug 2022 | 15,000 | 23,095 | - | 11.7 | 175,800 | Common Stock |
| Jeffrey Bolton | Director | Grant, award, or other acquisition of securities at price $ 13.37 per share. | 04 Aug 2022 | 3,000 | 10,597 | - | 13.4 | 40,110 | Common Stock |
| Jeffrey Bolton | Director | Purchase of securities on an exchange or from another person at price $ 11.74 per share. | 04 Aug 2022 | 1,000 | 7,597 | - | 11.7 | 11,740 | Common Stock |
| Leo I. Higdon | Director | Purchase of securities on an exchange or from another person at price $ 13.57 per share. | 03 Aug 2022 | 4,500 | 4,500 | - | 13.6 | 61,065 | Common Stock |
| Susan LaMonica | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 8,095 | 8,095 | - | 0 | Common Stock | |
| Tina L. Brown-Stevenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 8,095 | 8,095 | - | 0 | Common Stock | |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 6,597 | 56,333 | - | 0 | Common Stock | |
| Charles M. Elson | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 41,490 | 41,490 | - | 0 | Common Stock | |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 8,246 | 49,736 | - | 0 | Common Stock | |
| Gregory S. Rush | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 6,597 | 6,597 | - | 0 | Common Stock | |
| John E. Maupin | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 40,692 | 40,692 | - | 0 | Common Stock | |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 8,246 | 48,938 | - | 0 | Common Stock | |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 6,597 | 55,535 | - | 0 | Common Stock | |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 6,597 | 55,038 | - | 0 | Common Stock | |
| Leo I. Higdon | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 40,195 | 40,195 | - | 0 | Common Stock | |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 8,246 | 48,441 | - | 0 | Common Stock | |
| L. Edward Shaw | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 49,692 | 49,692 | - | 0 | Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 8,246 | 57,938 | - | 0 | Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 6,597 | 64,535 | - | 0 | Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 8,246 | 47,475 | - | 0 | Common Stock | |
| Yvonne M. Curl | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 39,229 | 39,229 | - | 0 | Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 6,597 | 54,072 | - | 0 | Common Stock | |
| Erin Hoeflinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 6,597 | 6,597 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 29,948 | 29,948 | - | - | Employee Stock Option (Right to Buy) | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 18,881 | 18,881 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 24,029 | 42,910 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 102,524 | 145,434 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 131,927 | 277,361 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 47,824 | 325,185 | - | 0 | Common Stock | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 19,204 | 19,204 | - | - | Employee Stock Option (Right to Buy) | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 35,091 | 35,091 | - | - | Employee Stock Option (Right to Buy) | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 42,459 | 42,459 | - | - | Employee Stock Option (Right to Buy) | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 40,965 | 40,965 | - | - | Employee Stock Option (Right to Buy) | |
| Barbara Jacobsmeyer | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 54,562 | 54,562 | - | - | Employee Stock Option (Right to Buy) | |
| Jeffrey Bolton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 6,597 | 6,597 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 8,930 | 8,930 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 17,384 | 26,314 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 21,988 | 58,057 | - | 0 | Common Stock | |
| Crissy B. Carlisle | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 9,755 | 36,069 | - | 0 | Common Stock | |
| Chad K. Knight | General Counsel | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 1,765 | 1,765 | - | 0 | Common Stock | |
| Chad K. Knight | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 15,392 | 17,157 | - | 0 | Common Stock | |
| Tanya R. Marion | Chief Human Resources Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 3,491 | 3,491 | - | 0 | Common Stock | |
| Tanya R. Marion | Chief Human Resources Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 4,907 | 8,398 | - | 0 | Common Stock | |
| Tanya R. Marion | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 11,544 | 19,942 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 14,527 | 30,584 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 1,355 | 1,355 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Other type of transaction at price $ 0.00 per share. | 01 Jul 2022 | 14,702 | 16,057 | - | 0 | Common Stock | |
| Julie D. Jolley | EVP of Home Health Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 17,151 | 47,735 | - | 0 | Common Stock |